CSIMarket
 


Pfenex Inc   (PFNX)
Other Ticker:  
 

Cumulative Pfenex Inc 's Quick Ratio for Trailing Twelve Months Period

PFNX's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

PFNX Quick Ratio for Trailing Twelve Months Period

(Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Current Liabilities Growth -16.44 % -45.75 % -50.06 % -43.52 % -54.42 %
Y / Y Cash & cash equivalent Growth 45.95 % 42.76 % -1.41 % -51.9 % -47.97 %
Quick Ratio for Trailing Twelve Months Period 6.36 5.53 4.35 3.6 3.68
Total Ranking # 435 # 471 # 588 # 655 # 684
Seq. Current Liabilities Growth 35.82 % -31.26 % -20.48 % 12.54 % -11.82 %
Seq. Cash & cash equivalent Growth -6.96 % 17.94 % 70.01 % -21.77 % -8.99 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Jun 30 2020
On the trailing twelve months basis Pfenex Inc Cash & cash equivalent average soared by 45.95% in II. Quarter year on year, while Current Liabilities grew to $ 8 millions, this led to increase in in Pfenex Inc 's Quick Ratio for Trailing Twelve Months Period to 6.36, Quick Ratio for Trailing Twelve Months Period remained below Pfenex Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 116 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Pfenex Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about PFNX
Quick Ratio PFNX in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 117
Sector # 176
S&P 500 # 307


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
9.1 5.31 3.07
(Sep 30 2015)   (Jun 30 2018)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Jun 30 2020, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Hoth Therapeutics Inc   17.42 
Seres Therapeutics Inc   17.20 
Agile Therapeutics Inc  16.92 
Milestone Pharmaceuticals inc   16.87 
Infinity Pharmaceuticals Inc   16.85 
Principia Biopharma Inc   16.69 
Crinetics Pharmaceuticals Inc   16.40 
Glycomimetics Inc   15.95 
Satsuma Pharmaceuticals Inc   15.80 
Prothena Corporation Public Limited Company  15.46 
Anaptysbio Inc   15.27 
Arcutis Biotherapeutics Inc   15.02 
Dianthus Therapeutics Inc   15.00 
Constellation Pharmaceuticals Inc  14.97 
Cymabay Therapeutics Inc   14.23 
Homology Medicines Inc  14.15 
Mustang Bio inc   13.94 
Equillium Inc   13.93 
G1 Therapeutics Inc   13.86 
Aravive Inc   13.79 
Synlogic Inc   13.70 
Myokardia Inc   13.55 
Revance Therapeutics Inc   13.46 
Savara Inc   13.41 
Provention Bio Inc   13.34 
Rocket Pharmaceuticals Inc   13.26 
Lexaria Bioscience Corp   13.24 
Aadi Bioscience Inc   13.20 
Sage Therapeutics Inc   13.09 
Adial Pharmaceuticals Inc   13.07 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com